Shen ding logo
Shen ding
Generic APIs

Eptifibatide Acetate,148031-34-9

Eptifibatide Acetate,148031-34-9


  • CAS#:148031-34-9


  • Product Name:Eptifibatide Acetate
  • Size:1g or more
  • Supply Ability:500g/two weeks
  • FOB Price:Email
  • Payment Terms:T/T
  • Lead time:Within 12 hours after receiving payment
  • Packing:Discreet ways of packing for Customs pass guaranteed
  • Delivery:by express (FedEx,UPS,DHL,EMS), by air
  • Download:MSDS
  • Contact Now
  • Specification
  • MSDS
  • Reviews

Eptifibatide Acetate-Physiochemical properties

      Sequence(Single-Letter Code): Map-KGDWPC -Amide,(Disulfide bond)

      Sequence(Three-Letter Code): MAP-Lys-Gly-Asp-Trp-Pro-Cys-Amide,(Disulfide bond)

      Molecular Formula: C35H49N11O9S2

      Molecular weight: 831.962 g/mol

      Storage:store in cool, dry, ventilated place

      PSA:     374.49000

      LogP:     1.62840

      RTECS:    HA0849000

      PubChem CID:    123610

      MDL Number:    MFCD05662245

      Beilstein Registry:    9608167


Eptifibatide Acetate Description

      Alternate Names:MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;INTEGRELIN;Eptifibatide;N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;Intrifiban;N6-(AMinoiMinoMethyl)-N2-(3-Mercapto-1-oxopropyl)-L-lysylglycyl-L-.alpha.-aspartyl-L-tryptophyl-L-prolyl-L-cysteinaMide Cyclic (16)-Disulfide;3-Mercaptopropionyl-HoMoarg-Gly-Asp-Trp-Pro-Cys-NH2

Eptifibatide is a specific inhibitor of fibrinogen binding to the platelet membrane integrin glycoprotein GPIIb/IIIa receptor, preventing platelet aggregation. Eptifibatide binds reversibly and competitively.

Eptifibatide Acetate Application

Eptifibatide is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the so called arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market.

Eptifibatide Acetate References

1. Plosker, G.L., et al. 2003. Pharmacoeconomics. 21: 885-912. PMID: 12908844

If not, Please tell me about your specific sequence. We provide the custom peptide synthesis for you.

Online Inquiry

Please feel free to give your inquiry in the form below.We will reply you in 24 hours.

return top